Add-on treatment with Epidiolex — an oral form of cannabidiol (CBD) — effectively drops the frequency of seizures in…
Articles by Marta Figueiredo, PhD
A gene therapy designed to increase the production of a subunit of the defective sodium channel in Dravet syndrome…
Seizures in people with Dravet syndrome may be associated with abnormal serotonin levels and activity in the brain,…
Selectively blocking NaV1.6 — a sodium channel known to be overactive in some epileptic conditions — may offer a way…
Researchers have reported a case of a child with Dravet syndrome who began to have seizures triggered by wiping during…
Researchers have identified two simple diagnostic criteria to help healthcare practitioners make an early and correct diagnosis of Dravet…
A zebra fish model of Dravet syndrome may be one of the best animal models to identify new therapeutic…
Zogenix’s lead investigational compound ZX008 provided significant and long-term seizure reduction in Dravet syndrome patients, according to new clinical trial data.
GW Pharmaceuticals has presented positive data on the safety and effectiveness of Epidiolex, recently approved by the U.S. Food and…
Specific nerve cells are critically involved in the development of epileptic seizures, hyperactivity, autistic-like behaviors, and cognitive declines in Dravet…